Mabvax Therapeutics Holdings Inc Share Price Other OTC
Equities
US55414P7024
Biotechnology & Medical Research
Sales 2016 | 148K 11.62M | Sales 2017 | - | Capitalization | 14.41M 1.13B |
---|---|---|---|---|---|
Net income 2016 | -17M -1.33B | Net income 2017 | -19M -1.49B | EV / Sales 2016 | 147 x |
Net Debt 2016 | 470K 36.9M | Net Debt 2017 | 2.48M 195M | EV / Sales 2017 | - |
P/E ratio 2016 |
-0.93
x | P/E ratio 2017 |
-0.25
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 92.02% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 72 | - | |
Chief Tech/Sci/R&D Officer | 81 | 07/07/14 | |
Paul W. Maffuid
CTO | Chief Tech/Sci/R&D Officer | 68 | 07/07/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 81 | 07/07/14 |
1st Jan change | Capi. | |
---|---|---|
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |